Member
AbViro LLC
AbViro is a Phase 2 clinical stage biotech company developing monoclonal antibody therapeutics for infectious diseases.
Industries
N/A
Nr. of Employees
small (1-50)
AbViro is a Phase 2 clinical stage biotech company developing monoclonal antibody therapeutics for infectious diseases.
N/A
small (1-50)